The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcome Academic Article uri icon

Overview

MeSH Major

  • Prostatic Neoplasms

abstract

  • The PCPT Risk Calculator overestimates risks for PSAs close to and above typical biopsy thresholds. Separating for-cause biopsies from end-of-study biopsies and using empirical rather than model-based risks reduces overall risk estimates and replicates prior findings that, in men who have been screened with PSA, there is no rapid increase in prostate cancer risk with higher PSA. Revision of the PCPT Risk Calculator should be considered.

publication date

  • June 3, 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3735626

Digital Object Identifier (DOI)

  • 10.1002/cncr.28114

PubMed ID

  • 23720006

Additional Document Info

start page

  • 3007

end page

  • 11

volume

  • 119

number

  • 16